文献速递主动脉疾病

年轻患者择期肾下腹主动脉瘤腔内与开放修复生存相当但中期耐久性较差

Inferior Mid-term Durability with Comparable Survival for Younger Patients Undergoing Elective Endovascular Infrarenal versus Open Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2019-10-18

这项单中心多医院回顾性研究纳入2003至2013年253例70岁以下择期肾下腹主动脉瘤患者,其中EVAR 204例、OSR 49例。两组围手术期无死亡且生存无差异,但OSR的无再干预生存、无任何再干预及无腔内再干预均优于EVAR;EVAR中颈长不符合标准IFU者死亡或再干预风险更高。

要点

  • 年轻患者EVAR与OSR围手术期死亡及中期生存无差异。
  • EVAR总再干预及腔内再干预风险高于OSR。
  • EVAR颈长不符合标准IFU者死亡或再干预风险更高。

核心结论

  • 年轻患者择期肾下腹主动脉瘤EVAR与OSR围手术期死亡及随访生存无显著差异。
  • EVAR总再干预和腔内再干预多于OSR,中期耐久性较差。

研究设计与样本

  • 单中心多医院回顾性研究,纳入2003至2013年253例70岁以下择期初发肾下腹主动脉瘤患者。
  • EVAR 204例(80.6%),OSR 49例(19.4%),采用多变量Cox比例风险模型和负二项回归校正基线临床及动脉瘤特征。

主要发现

  • 两组围手术期均无死亡,基线人口学和合并症相似。
  • OSR组新发心律失常(EVAR 1.0% vs OSR 10.2%,P=0.004)、中位住院时间(EVAR 1天 vs OSR 5天,P<0.001)和出院至机构比例(EVAR 2.9% vs OSR 12.2%,P=0.016)均显著更高。
  • 两组中位随访4.5年,生存无差异;OSR较EVAR的无死亡且无再干预复合终点风险比HR 4.3(P=0.009)、无任何再干预RR 4.08(P=0.030)、无任何腔内再干预RR 4.83(P=0.038)均更高。
  • EVAR颈长不符合标准IFU者死亡或再干预风险更高(HR 4.90,P=0.001)。

临床怎么用

  • 年轻择期肾下腹主动脉瘤患者选择EVAR需权衡其中期再干预风险高于OSR。
  • EVAR术前应评估颈长是否符合标准IFU,不符合者死亡或再干预风险更高。

局限性

  • 回顾性单中心多医院研究,样本量有限(尤其OSR组49例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The durability of endovascular aneurysm repair (EVAR) when compared to open surgical repair (OSR) in younger patients for elective, infrarenal abdominal aortic aneurysms (AAA) remains unclear due to limited follow-up. METHODS: We identified all patients <70 years of age who underwent elective, de novo EVAR or OSR for infrarenal AAA from 2003 to 2013 in a multihospital, single institution. Baseline patient clinical and aneurysmal characteristics were adjusted for using multivariable Cox proportional hazards models and negative binomial regression. RESULTS: We identified 253 patients: 204 underwent EVAR (80.6%) and 49 OSR (19.4%). Baseline demographics and comorbidities were similar across groups. There were no deaths in the immediate perioperative period. The rate of new arrhythmia (EVAR: 1.0%, OSR: 10.2%; P = 0.004), median hospital length of stay (EVAR: 1 day, OSR: 5 days; P < 0.001), and discharge to a facility (EVAR: 2.9%, OSR: 12.2%; P = 0.016) were significantly increased for OSR. In both groups, median follow-up time was 4.5 years, in which survival did not differ between groups. The hazard of composite of freedom from death and any reinterventions (hazard ratio [HR] 4.3, P = 0.009), freedom from any reintervention (relative risk [RR] 4.08, P = 0.030), and freedom from any endovascular reintervention (RR 4.83, P = 0.038) were each higher for OSR when compared to EVAR. EVAR of the standard instruction for use (IFU) for neck length was more likely to die or undergo a reintervention (HR 4.90, P = 0.001). CONCLUSIONS: Our retrospective review of younger patients undergoing elective AAA repair demonstrated no significant differences in perioperative mortality or survival over time between EVAR and OSR. EVAR required more total reinterventions and endovascular reintervention when compared to OSR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Reitz KM, Liang NL, Xie B, et al. Inferior Mid-term Durability with Comparable Survival for Younger Patients Undergoing Elective Endovascular Infrarenal versus Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2019. PMID: 31634607. doi:10.1016/j.avsg.2019.10.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。